BRIDGEBIO PHARMA INC (BBIO) Institutional Ownership Changes & 13F Activity
BRIDGEBIO PHARMA INC (BBIO). Institutional ownership data tracks hedge funds, asset managers, and other institutional investors based on recent SEC Form 13F filings (Q2 2026). This page analyzes institutional buying and selling activity, new holdings, and sold-out positions in the latest reporting period. Notable filers include California State Teachers Retirement System, Citadel Advisors Llc, Wellington Management Group Llp, Price T Rowe Associates Inc, and Manufacturers Life Insurance Company, The.
| Institution | Type | Change in shares | Change Position % | Shares | Reported stock balance | Portfolio quarter | Filing date |
|---|---|---|---|---|---|---|---|
| Manufacturers Life Insurance Company, The | Buy | +1,934,386 | +97.8% | 3,911,466 | $291.33M | Q2 2026 | Sep 09, 2026 |
| Parkside Financial Bank & Trust | Sell | -66 | -26.6% | 182 | $13.56K | Q2 2026 | Sep 04, 2026 |
| Citadel Advisors Llc | Buy | +4,346,116 | +136.9% | 7,520,056 | $560.09M | Q2 2026 | Sep 02, 2026 |
| Allianz Asset Management Gmbh | Buy | +4,800 | +49.0% | 14,600 | $1.09M | Q2 2026 | Sep 02, 2026 |
| Cornerstone Financial Management Llc | Sell | -14 | -100.0% | 0 | $0.00 | Q2 2026 | Aug 28, 2026 |
| Corient Private Wealth Llc | Buy | +47,571 | +195.9% | 71,850 | $5.35M | Q2 2026 | Aug 27, 2026 |
| California State Teachers Retirement System | Buy | +12,534,939 | +7564.7% | 12,700,642 | $12.70M | Q2 2026 | Aug 24, 2026 |
| Harvey Capital Management Inc | Buy | +220,385 | +384.7% | 277,670 | $20.68M | Q2 2026 | Aug 21, 2026 |
| Assenagon Asset Management S.A. | Sell | -12,852 | -29.1% | 31,240 | $2.33M | Q2 2026 | Aug 21, 2026 |
| Harvest Fund Management Co., Ltd | Sell | -46 | -4.9% | 892 | $66.00K | Q2 2026 | Aug 20, 2026 |
| Mercer Global Advisors Inc | Buy | +6,749 | — | 6,749 | $502.70K | Q2 2026 | Aug 19, 2026 |
| Fulcrum Asset Management Llp | Buy | +4,456 | — | 4,456 | $320.88K | Q2 2026 | Aug 18, 2026 |
| Jefferies Financial Group Inc. | Buy | +71,315 | +86.7% | 153,615 | $11.44M | Q2 2026 | Aug 17, 2026 |
| Public Employees Retirement System Of Ohio | Buy | +48,191 | — | 48,191 | $3.59M | Q2 2026 | Aug 17, 2026 |
| Transamerica Financial Advisors, Llc | Buy | +2 | +25.0% | 10 | $744.00 | Q2 2026 | Aug 17, 2026 |
| Wellington Management Group Llp | Buy | +2,824,971 | +113.7% | 5,308,924 | $395.41M | Q2 2026 | Aug 14, 2026 |
| Price T Rowe Associates Inc | Sell | -2,075,272 | -54.6% | 1,726,383 | $128.58M | Q2 2026 | Aug 14, 2026 |
| Frazier Life Sciences Management, L.P. | Sell | -1,900,000 | -55.1% | 1,548,139 | $115.31M | Q2 2026 | Aug 14, 2026 |
| Viking Global Investors | Sell | -1,893,215 | -16.0% | 9,949,219 | $741.02M | Q2 2026 | Aug 14, 2026 |
| Sixth Street Partners Management Company, L.P. | Buy | +1,709,417 | — | 1,709,417 | $127.32M | Q2 2026 | Aug 14, 2026 |
| Adage Capital Partners Gp, L.L.C. | Buy | +1,653,000 | +276.0% | 2,252,000 | $167.73M | Q2 2026 | Aug 14, 2026 |
| Two Sigma Investments, Lp | Buy | +1,601,554 | +51.3% | 4,722,185 | $351.71M | Q2 2026 | Aug 14, 2026 |
| Point72 Asset Management, L.P. | Buy | +1,525,782 | — | 1,525,782 | $113.64M | Q2 2026 | Aug 14, 2026 |
| Farallon Capital Management Llc | Buy | +1,377,600 | +14.7% | 10,743,063 | $800.14M | Q2 2026 | Aug 14, 2026 |
| Jane Street Group, Llc | Buy | +1,176,521 | +66.9% | 2,934,193 | $218.54M | Q2 2026 | Aug 14, 2026 |
| Bellevue Group Ag | Buy | +1,164,129 | +4587.3% | 1,189,506 | $88.59M | Q2 2026 | Aug 14, 2026 |
| D. E. Shaw & Co., Inc. | Buy | +1,087,521 | +42.7% | 3,633,007 | $270.59M | Q2 2026 | Aug 14, 2026 |
| Hrt Financial Lp | Buy | +1,017,511 | +1415.9% | 1,089,376 | $81.14M | Q2 2026 | Aug 14, 2026 |
| Ameriprise Financial Inc | Sell | -945,379 | -37.9% | 1,551,663 | $115.57M | Q2 2026 | Aug 14, 2026 |
| Ensign Peak Advisors, Inc | Sell | -912,127 | -54.5% | 760,977 | $56.68M | Q2 2026 | Aug 14, 2026 |
Frequently asked questions about BBIO activity
Which institutional owners are buying BBIO?
Institutional owners buying BBIO include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.
What does "buy" mean in BBIO activity?
"Buy" means an investor increased their reported position in BBIO compared to the prior reporting period. This reflects growing exposure to BRIDGEBIO PHARMA INC (BBIO) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).
Is institutional interest in BBIO increasing?
Institutional interest in BBIO can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.
Related BBIO Institutional Insights
- BBIO Overview
- BBIO 13F Institutional Holders
- BBIO Top Institutional Shareholders
- Healthcare Sector Institutional Ownership
- Healthcare Sector Portfolio Overlap
- Institutional Portfolio Overlap & Shared Holdings
- Most Bought Healthcare Stocks By Institutional Investors
- Most Sold Healthcare Stocks By Institutional Investors
- BBIO Insider Trading & SEC Form 4 Activity
- BBIO Articles
- Top Institutional Investor Stock Rankings